-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EQ-101 in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EQ-101 in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EQ-101 in Alopecia Areata Drug Details: EQ-101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EQ-102 in Celiac Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EQ-102 in Celiac Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EQ-102 in Celiac DiseaseDrug Details:EQ-102 is under development for the treatment of celiac...
-
Product Insights
Net Present Value Model: BNZ-1
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model BNZ-1 Drug Details EQ-101 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EQ-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry EQ-101 Drug Details EQ-101 is under development for the treatment of T-cell leukemias including...
-
Product Insights
T-Cell Leukemia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2018" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
T-Cell Leukemia Disease – Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2019" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...